New combo attack on breast cancer brain tumors

NCT ID NCT04923542

Recruiting now Disease control Sponsor: H. Lee Moffitt Cancer Center and Research Institute Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a targeted drug called abemaciclib to precise radiation treatment can better control breast cancer that has spread to the brain. It is for people with a specific type of breast cancer (hormone receptor-positive, HER2-negative) who have a limited number of brain tumors. The main goal is to see how long the treatment can keep the cancer in the brain from getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Moffitt Cancer Center
ACTIVE_NOT_RECRUITING

Tampa, Florida, 33612, United States
Ohio State University Comprehensive Cancer Center
RECRUITING

Columbus, Ohio, 43210, United States

Contact

Conditions

Explore the condition pages connected to this study.

BRAIN METASTASES HR+ METASTATIC BREAST CANCER